nx-1607,detil-0255
nurix therapeutics
['nx-1607 ', 'detil-0255 ', '$nrix']
nurix will present three clinical trial in progress posters featuring the ongoing studies of our btk degrader nx-2127, cbl-b inhibitor nx-1607 and adoptive cell therapy detil-0255 at #asco2022 from june 3-7. read our press release for more details: $nrix 
Targeted #proteindegradation is only the beginning. Blazing a new path in medicine. $NRIX